• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparative conformational analysis of CCK-B agonist Boc-Trp-Phg-Asp-(1-Nal)-NH2 and CCK1-B antagonist Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 using 1HNMR spectroscopy and restrained molecular dynamics.

作者信息

Goudreau N, Weng J H, Roques B P

机构信息

Départment de Pharmacochimie Moléculaire et Structurale, U266 INSERM-URA D1500 CNRS, U.F.R. des Sciences Pharmaceutiques et Biologiques, Paris, France.

出版信息

Arch Pharm (Weinheim). 1996 Apr;329(4):197-204. doi: 10.1002/ardp.19963290405.

DOI:10.1002/ardp.19963290405
PMID:8669984
Abstract

The tetrapeptide Boc-Trp-Phg-Asp-(1-Nal)-NH2 is a potent CCK-B agonist. Interestingly, bis-methylation of the C-terminal carboxamide group of this compound leads to Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 which behaves as a CCK-B antagonist in electrophysiological studies on hippocampal neurones (Corringer et al., 1993). In order to ascertain whether bismethylation of the terminal carboxamide group has an influence on the conformational preferences of the peptide, we have undertaken a comparative conformational analysis of the two tetrapeptides by the combined use of 2D NMR spectroscopy and restrained molecular dynamics. The solution conformation of the two peptides were examined by 1H NMR in a d6-DMSO/H2O (80:20) mixture. 1H-1H distance constraints, derived from 2D NOESY and ROESY experiments, were used as inputs for subsequent restrained molecular dynamics simulations. Comparison of the NMR and molecular modeling data indicates different conformational preferences for these two peptides. Interestingly, the aromatic side chains of the CCK-B antagonist Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 in its preferential conformation, overlap their corresponding moieties in the two non peptide CCK-B antagonists L-362,260 and LY-288,513. The differences in conformational behaviour of the studied tetrapeptides could, at least in part, account for their opposite agonist/antagonist profile, a findings which could serve for the design of new conformationally restricted CCK-B analogs.

摘要

相似文献

1
Comparative conformational analysis of CCK-B agonist Boc-Trp-Phg-Asp-(1-Nal)-NH2 and CCK1-B antagonist Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 using 1HNMR spectroscopy and restrained molecular dynamics.
Arch Pharm (Weinheim). 1996 Apr;329(4):197-204. doi: 10.1002/ardp.19963290405.
2
Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2.使用1H-NMR和受限分子动力学对CCK-B激动剂进行构象分析:生物活性的Boc-Trp-(N-Me)Nle-Asp-Phe-NH2与无活性的Boc-Trp-(N-Me)Phe-Asp-Phe-NH2的比较。
Biopolymers. 1994 Feb;34(2):155-69. doi: 10.1002/bip.360340202.
3
Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.N-末端和C-末端取代基对Boc-Trp-Phg-Asp-Nal-NH2衍生物的CCK-B激动剂-拮抗剂药理特性的作用
Bioorg Med Chem. 1996 Apr;4(4):563-73. doi: 10.1016/0968-0896(96)00050-8.
4
CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.结构受阻且耐肽酶的Boc-CCK4衍生物的CCK-B激动剂或拮抗剂活性
J Med Chem. 1993 Jan 8;36(1):166-72. doi: 10.1021/jm00053a022.
5
Cyclic cholecystokinin-analog pentapeptide cyclo (Asp-Trp-Met-Asp-Phe): an unexpected solution conformation.环胆囊收缩素类似物五肽环(天冬氨酸-色氨酸-甲硫氨酸-天冬氨酸-苯丙氨酸):一种意想不到的溶液构象。
Biochem Biophys Res Commun. 1995 Aug 15;213(2):506-12. doi: 10.1006/bbrc.1995.2160.
6
Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.Boc-色氨酸-鸟氨酸(Z)-天冬氨酸-氨基及衍生物:一类新型的胆囊收缩素拮抗剂
J Med Chem. 1990 Dec;33(12):3199-204. doi: 10.1021/jm00174a016.
7
CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).源自CCK-A受体选择性四肽激动剂Boc-Trp-Lys(Tac)-Asp-MePhe-NH2(A-71623)的CCK-A受体选择性拮抗剂。
J Med Chem. 1995 Jan 6;38(1):207-11. doi: 10.1021/jm00001a027.
8
Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.肽三维结构模拟物的开发:新型类肽胆囊收缩素受体拮抗剂的合理设计。
J Med Chem. 2000 Sep 21;43(19):3505-17. doi: 10.1021/jm000937a.
9
Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.天冬氨酸-苯丙氨酸-氨基部分已被3-氨基-7-苯基庚酸或3-氨基-6-(苯氧基)己酸取代的胆囊收缩素类似物的合成及生物学评价
J Med Chem. 1993 Oct 1;36(20):3021-8. doi: 10.1021/jm00072a024.
10
Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.基于结构的胆囊收缩素CCK-B受体新型环状激动剂的设计
J Med Chem. 1997 Feb 28;40(5):647-58. doi: 10.1021/jm9603072.